SANG(SANG)
SANG
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $209M | $227M |
| Low | $207M | $223M |
| High | $212M | $232M |
| EBITDA Avg | $120M | $131M |
| Low | $119M | $128M |
| High | $122M | $133M |
| EBIT Avg | $86M | $94M |
| Low | $85M | $92M |
| High | $87M | $96M |
| Net Income Avg | $-937,922 | $14M |
| Low | $-2M | $14M |
| High | $-133,988 | $15M |
| EPS Avg | $-0.03 | $0.43 |
| Low | $-0.05 | $0.42 |
| High | $-0.00 | $0.44 |
| Analysts (Rev / EPS) | 4 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $51M | $52M | $52M | $52M | $56M | $57M | $57M | $58M |
| Low | $50M | $51M | $51M | $51M | $55M | $56M | $56M | $57M |
| High | $52M | $53M | $53M | $53M | $57M | $57M | $58M | $59M |
| EBITDA Avg | $29M | $30M | $30M | $30M | $32M | $32M | $33M | $33M |
| Low | $29M | $29M | $29M | $30M | $32M | $32M | $32M | $33M |
| High | $30M | $30M | $30M | $30M | $33M | $33M | $33M | $34M |
| EBIT Avg | $21M | $21M | $21M | $21M | $23M | $23M | $24M | $24M |
| Low | $21M | $21M | $21M | $21M | $23M | $23M | $23M | $24M |
| High | $21M | $22M | $22M | $22M | $23M | $24M | $24M | $24M |
| Net Income Avg | $-2M | $-2M | $-2M | $-1M | — | — | — | — |
| Low | $-2M | $-2M | $-2M | $-1M | — | — | — | — |
| High | $-2M | $-2M | $-2M | $-1M | — | — | — | — |
| EPS Avg | $-0.07 | $-0.07 | $-0.05 | $-0.04 | — | — | — | — |
| Low | $-0.07 | $-0.07 | $-0.05 | $-0.04 | — | — | — | — |
| High | $-0.07 | $-0.06 | $-0.05 | $-0.04 | — | — | — | — |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / — | 1 / — | 1 / — | 1 / — |